GreenLight Biosciences Holdings, PBC Quarterly Debt-to-equity in % from Q3 2021 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GreenLight Biosciences Holdings, PBC quarterly Debt-to-equity history and growth rate from Q3 2021 to Q1 2023.
  • GreenLight Biosciences Holdings, PBC Debt-to-equity for the quarter ending March 31, 2023 was 205 %, a 22% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 205 -57.9 -22% Mar 31, 2023
Q4 2022 148 -63.5 -30% Dec 31, 2022
Q3 2022 230 +204 +787% Sep 30, 2022
Q2 2022 492 Jun 30, 2022
Q1 2022 263 Mar 31, 2022
Q4 2021 212 Dec 31, 2021
Q3 2021 26 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.